P.014 Eptinezumab improved work productivity in adults with migraine and prior preventive treatment failures: results from the DELIVER study
Goadsby, PJ, Barbanti, P, Lambru, G, Ettrup, A, Laurberg Christoffersen, C, Krog Josiassen, M, Phul, R, Sperling, B, Gohil, V
Published in Canadian journal of neurological sciences (01.06.2023)
Published in Canadian journal of neurological sciences (01.06.2023)
Get full text
Journal Article
P.016 Impact of eptinezumab on patient-reported outcomes in patients with prior preventive treatment failures
Goadsby, PJ, Barbanti, P, Ettrup, A, Laurberg Christoffersen, C, Krog Josiassen, M, Phul, R, Sperling, B, Duong, A
Published in Canadian journal of neurological sciences (01.06.2023)
Published in Canadian journal of neurological sciences (01.06.2023)
Get full text
Journal Article
P.027 Efficacy and Safety of Eptinezumab Initiated During a Migraine Attack: Results from the RELIEF Study
Winner, PK, McAllister, P, Chakhava, G, Ailani, J, Mehta, L, Ettrup, A, Krog Josiassen, M, Lindsten, A, Bougie, JK, Cady, R
Published in Canadian journal of neurological sciences (01.11.2021)
Published in Canadian journal of neurological sciences (01.11.2021)
Get full text
Journal Article
P.3.c.052 Long-term efficacy and safety of bifeprunox in stable patients with schizophrenia: findings from a 6-month study
Bourin, M, Debelle, M, Heisterberg, J, Krog Josiassen, M, Buch Østergaard, J, Sands, E.A, Yeung, P.P
Published in European neuropsychopharmacology (2007)
Published in European neuropsychopharmacology (2007)
Get full text
Journal Article